Manuel Cappellari Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

5/2022	Association of statin pre-treatment with baseline stroke severity and outcome in patients with acute ischemic stroke and received reperfusion treatment: An observational study.
2/2015	Cardioembolic stroke in the THRombolysis and STatins (THRaST) study.
6/2013	Letter by Cappellari et al regarding article, "statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and Randomized Trials".
2/2013	The THRombolysis and STatins (THRaST) study.
9/2011	Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manuel Cappellari Research Topics

Disease

47	Stroke (Strokes) 08/2022 - 09/2011
37	Ischemic Stroke 06/2022 - 09/2011
23	Atrial Fibrillation 01/2022 - 01/2012
11	Hemorrhage 08/2022 - 02/2013
7	Cerebral Hemorrhage 01/2021 - 09/2011
4	Embolic Stroke 01/2019 - 01/2012
3	Hypertension (High Blood Pressure) 01/2021 - 01/2012
2	Infarction (Infarctions) 08/2022 - 01/2018
2	Blood Vessel Dissection 01/2022 - 10/2017
2	COVID-19 11/2021 - 01/2021
2	Hyperlipidemias (Hyperlipidemia) 04/2021 - 01/2012
2	Heart Failure 04/2021 - 01/2012
2	Neoplasms (Cancer) 12/2020 - 02/2013
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 01/2019
2	Hyperglycemia 01/2019 - 03/2018
1	Transient Ischemic Attack 01/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 11/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2021
1	Dementia (Dementias) 04/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Bacterial Endocarditis 12/2020
1	Liver Diseases (Liver Disease) 12/2020
1	Leukoaraiosis 01/2019
1	Hyperthermia 03/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2017
1	Patent Foramen Ovale 08/2017
1	Lacunar Stroke 01/2014
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 02/2013
1	Diabetes Mellitus 01/2012
1	Amyloidosis 06/2011
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/2011

Drug/Important Bio-Agent (IBA)

26	AnticoagulantsIBA 01/2022 - 02/2013
8	Vitamin K FDA Link 01/2022 - 11/2017
8	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2012
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 09/2011
3	ORALIT (ORS)IBA 08/2022 - 03/2018
3	Dabigatran FDA Link 04/2021 - 05/2017
3	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2019 - 01/2012
3	Blood Glucose (Blood Sugar)IBA 09/2018 - 01/2012
2	LipidsIBA 01/2021 - 01/2020
2	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 10/2016
2	Particulate MatterIBA 09/2018 - 02/2018
2	RivaroxabanIBA 01/2018 - 11/2017
2	apixabanIBA 11/2017 - 09/2017
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Apolipoprotein C-IIIIBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 12/2020
1	Anesthetics (Anesthetic Agents)IBA 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	Air Pollutants (Pollutants, Air)IBA 02/2018
1	Nitrogen DioxideIBA 02/2018
1	3-O-(2'-acetoxy)benzoyl-2-glucopyranoseIBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	Clopidogrel (Plavix)FDA Link 01/2018
1	idarucizumabIBA 05/2017
1	CholesterolIBA 01/2012
1	Cerebrospinal Fluid ProteinsIBA 06/2011
1	Prealbumin (Transthyretin)IBA 06/2011

Therapy/Procedure

20	Thrombectomy 08/2022 - 08/2017
13	Therapeutics 01/2022 - 06/2013
7	Secondary Prevention 01/2022 - 10/2014
2	Punctures 08/2022 - 01/2020
2	Endovascular Procedures 05/2021 - 10/2014
2	Conscious Sedation 11/2020 - 01/2020
2	Local Anesthesia 11/2020 - 01/2020
2	General Anesthesia 11/2020 - 01/2020
2	Thrombolytic Therapy 01/2020 - 01/2012
1	Contraindications 11/2021
1	Conservative Treatment 11/2021
1	Time-to-Treatment 01/2021
1	Aftercare (After-Treatment) 01/2019
1	Activities of Daily Living (ADL) 01/2012